Provided by Tiger Trade Technology Pte. Ltd.

Ligand Pharmaceuticals

280.18
-6.1100-2.13%
Volume:158.24K
Turnover:44.66M
Market Cap:5.59B
PE:28.85
High:286.27
Open:286.27
Low:279.87
Close:286.29
52wk High:326.63
52wk Low:158.13
Shares:19.94M
Float Shares:19.35M
Volume Ratio:0.86
T/O Rate:0.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):9.71
EPS(LYR):6.13
ROE:21.96%
ROA:3.99%
PB:5.77
PE(LYR):45.71

Loading ...

Apr 07, 2020

Major Issues Report

Current report, item 1.01
Apr 06, 2020

Major Issues Report

Current report, items 2.02 and 8.01
Apr 02, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Feb 27, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 06, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Jan 10, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 10, 2020

Major Issues Report

Current report, item 8.01
Dec 23, 2019

Major Issues Report

Current report, item 5.02
Nov 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 05, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Oct 16, 2019

Major Issues Report

Current report, items 5.02, 7.01, and 9.01